MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$65,002,305
Prepaid expenses and
other current assets
$1,271,514
Total current assets
$66,273,819
Right-of-use assets
$209,262
Total assets
$66,483,081
Total liabilities and
stockholders equity
$66,483,081
Total stockholders
equity
$42,156,792
Total liabilities
$24,326,289
Accumulated deficit
-$487,409,872
Additional paid-in capital
$529,506,343
Total current
liabilities
$24,326,289
Common stock, voting,
0.001 par value...
$60,321
Current portion of debt
$15,300,000
Deferred collaboration
revenue
$6,000,000
Accrued expenses
$2,672,164
Operating lease
liabilities
$212,769
Accounts payable
$141,356
Back
Back
Balance Sheet
source: myfinsight.com
Aldeyra Therapeutics, Inc. (ALDX)
Aldeyra Therapeutics, Inc. (ALDX)